Advanced Practice Providers Oncology Summit

ONLINE ON DEMAND CME COURSES IN ONCOLOGY

Oncology 101: A Hematology and Oncology Primer for Advanced Practice Providers (On-Demand) Fall 2023

The demand for cancer care is expected to grow 40% over the next six years and ASCO is projecting a shortage of more than 2,200 oncologists by 2025. To meet the cancer care needs of patients, advanced practice providers (APPs), whose education and training is focused on health promotion, disease prevention, and primary care medical management, have increasingly been sought to filled the shortage. However, many APPs have little background or training in oncology. As a result, oncology practices need to provide new staff with an onboarding program that helps to establish a working baseline level of knowledge of hematology and oncology.

To help APPs prepare for a new career in the specialty of oncology, Horizon CME has developed “Oncology 101: A Hematology and Oncology Primer for Advanced Practice Providers”. In this on-demand program with updates and content from the Spring 2023 virtual Oncology 101 conference, clinicians will gain a basic understanding of cancer therapies, benign and malignant hematologic disorders, solid malignancies, supportive care strategies, oncologic emergencies, genetics and molecular testing, and more. Participation in this program will provide APPs with the foundational knowledge they need to provide support and care to cancer patients as part of the multidisciplinary oncology care team. 

(Course access available through November 16, 2024)

Registration

$125

Target Audience

This program is appropriate for new APPs, nurses, and pharmacists in oncology, clinicians seeking a review, or clinicians considering a career in oncology.

Conference Planning Committee

Beth Faiman

PhD, MSN, APRN-BC, AOCN, FAAN

Nurse Practitioner

Department of Hematology and Medical Oncology – Cleveland Clinic 

Val R. Adams

PharmD, FCCP, FHOPA, BCOP

Associate Professor, Oncology Specialist

University of Kentucky

Beth Sandy

MSN, CRNP

Nurse Practitioner, Thoracic Medical Oncology

Abramson Cancer Center, University of Pennsylvania

PRESENTING FACULTY

Jennie M. Goble, PA-C

Instructor in Medicine - Mayo Clinic Rochester, MN

Justin Baker, MD

Chief, Division of Quality of Life and Palliative Care St. Jude Children's Research Hospital - Memphis TN

Lauren Imboden, MMS, PA-C

Physician Assistant Atrium Health Wake Forest Baptist Winston Salem, NC

Marianne Davies, DNP, ACNP, AOCNP, FAAN

Nurse Practitioner Yale Comprehensive Cancer Center New Haven, CT

Sandra Cuellar Puri, PharmD, BCOP

Clinical Oncology Pharmacist University of Illinois College of Pharmacy Chicago, IL

Jennifer Murphy, PharmD, BCOP, BCPS

Senior Pharmacist UCD Health, Oncology & Investigational Drug Service San Francisco, CA

Ellen Marin, PA-C

Physician Assistant Winship Cancer Institute of Emory University Atlanta, GA

Meredith Beaton, MSN, RN, AG-ACNP

Nurse Practitioner UCHealth Anschutz Aurora, CO

Laura J. Zitella, MS, RN, ACNP-BC, AOCN

Associate Clinical Professor University Of California San Francisco Hematology/Oncology Nurse Practitioner San Francisco, CA

Jessica Walchonski, PA-C

Physician Assistant UCLA Health Los Angeles, CA

Kathleen Boyle, DScPAS, PA-C

Physician Assistant Dana-Farber Cancer Institute Boston, MA

Linda M. Perry, PA-C

Physician Assistant Hematology Perelman Center for Advanced Medicine Philadelphia, PA

Grace Baek, PharmD, BCOP

Clinical Pharmacist, Hematology/Oncology Fred Hutchinson Cancer Center Seattle, WA

Patricia Mangan, RN, MSN, CRNP

Nurse Lead, Hematologic Malignancies Program Abramson Cancer Center, University of Pennsylvania Philadelphia, PA

Laura Wood, RN, MSN, OCN

Nurse Cleveland Clinic, Taussig Cancer Center Cleveland, OH

Michael Lai, ARNP

Nurse Practitioner Fred Hutchinson Cancer Center Seattle, WA

Jamie Carroll APRN, CNP, MSN

Nurse Practitioner Mayo Clinic Rochester, MN

Matthew Robinson DO, MS

Attending Physician Associate Medical Director of Hospice Baptist Memorial Hospital Memphis, TN

Korie Bigbee DNP

Nurse Practitioner Specialist Kaiser Permanente at City of Hope Duarte CA

Heather Koniarczyk, MSN, APRN-CNP, AOCNP

Adult Nurse Practitioner Cleveland Clinic -Taussig Cancer Institute Cleveland, OH

Lisa Nodzon PhD, APRN, AOCNP

Nurse Practitioner H. Lee Moffitt Cancer Center and Research Institute Tampa, FL

FINANCIAL DISCLOSURES & CONFLICTS OF INTEREST

DISCLOSURES:

In accordance with the ACCME Standards for Integrity and Independence in Accredited Continuing Education, Horizon CME (HCME) ensures that continuing education activities are balanced, independent, objective, and scientifically rigorous.

All persons in a position to influence the content of an accredited continuing education activity provided by Horizon CME are required to disclose to HCME any relevant financial relationships with ineligible companies within the past 24 months. All reported relevant financial relationships have been mitigated by Horizon CME.

 

Faculty, Authors, and Content Developers Disclosures:

  • Laura J. Zitella, MS, RN, ACNP-BC, AOCN discloses Speaker’s Bureau with Abbvie but that relationship has ended with during the past 24 months.
  • Beth Faiman, PhD, MSN, APN-BC, AOCN, BMTCN, FAAN discloses Advisory Board and Consulting Fee with Janssen, Sanofi, Karyopharm during the past 24 months.
  • Beth Sandy, MSN, CRNP discloses Speaker’s Bureau with Lilly, Amgen, AstraZeneca, Takeda, Jazz, Merck and Consulting Fee with Janssen during the past 24 months.
  •  Lisa Nodzon PhD, APRN, AOCNP discloses Speaker’s Bureau with Pharmacyclics AstraZeneca and Speaker’s Bureau with Takeda and Genentech/AbbVie but that relationship has ended.Advisory Board with BeiGene; Pharmacyclics, Novartis and Consulting Fee with AstraZeneca; AbbVie during the past 24 months.
  • Sandra Cuellar, PharmD, BCOP, FHOPA, FASHP discloses Speaker’s Bureau with Mirati and Advisory Boards with Genentech during the past 24 months.
  • Lauren Imboden, PA-C discloses Speaker’s Bureau with Sobi and Advisory Boards with Sanofi during the past 24 months.
  • Linda M. Perry, MS, PA-C discloses Speaker’s Bureau with Incyte and Advisory Board with Incyte and Sanofi during the past 24 months.
  • Patricia Mangan, RN, MSN, CRNP discloses Speaker’s Bureau and Advisory Boards with BMS and Janssen but that relationship has ended during the past 24 months.
  • Matthew Robinson, DO, MS discloses contracted research with American Osteopathic Association during the past 24 months.
  • Jamie Carroll, APRN, CNP, MSN discloses Advisory Board Pfizer, Novartis, Sermonix, Eli Lilly, AstraZeneca and Consulting Fee with Research to practice but all of these relationships have ended during the past 24 months.
  • Jessica Walchonski, PA-C discloses Advisory Boards with Immunogen but that relationship has ended during the past 24 months.
  • Jennifer Murphy, PharmD, BCOP discloses Speaker’s Bureau with McCreadie but that relationship has ended and Ownership interest with AbbVie, Moderna during the past 24 months.
  • Laura S. Wood, RN, MSN, OCN discloses Speaker’s Bureau with AVEO, BMS, EMD Serono, Exelixis, Merck, Pfizer during the past 24 months.
  • Michael Lai, ARNP discloses Advisory Boards with Janssen, Bayer, Astellas, Seagen but these relationships have ended during the past 24 months.

Planners:

  • Beth Faiman, PhD, MSN, APN-BC, AOCN, BMTCN, FAAN discloses Advisory Board and Consulting Fee with Janssen, Sanofi, Karyopharm during the past 24 months.
  • Beth Sandy, MSN, CRNP discloses Speaker’s Bureau with Lilly, Amgen, AstraZeneca, Takeda, Jazz, Merck and Consulting Fee with Janssen during the past 24 months
  • Val R. Adams, PharmD, FCCP, FHOPA, BCOP discloses the following relevant financial relationships: Regeneron and BMS.